Predictions
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.71
14.05.24
14.05.24
€3.00
14.05.25
14.05.25
25.85%
15.05.24
15.05.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Insmed Inc.
Start price
Target price
Perf. (%)
€23.60
13.05.24
13.05.24
€15.00
13.05.25
13.05.25
0.00%
14.05.24
14.05.24
Could be very worthwhile Investment >20% year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.36
13.05.24
13.05.24
€2.00
13.05.25
13.05.25
14.74%
14.05.24
14.05.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Novavax Inc.
Start price
Target price
Perf. (%)
€8.70
11.05.24
11.05.24
€82.00
11.05.25
11.05.25
37.40%
19.05.24
19.05.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
MacroGenics Inc.
Start price
Target price
Perf. (%)
€4.37
10.05.24
10.05.24
-
10.05.25
10.05.25
-27.99%
12.05.24
12.05.24
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.96
10.05.24
10.05.24
-
10.05.25
10.05.25
4.80%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Heartland Express Inc.
Start price
Target price
Perf. (%)
€10.20
03.05.24
03.05.24
€18.00
03.05.25
03.05.25
5.88%
13.05.24
13.05.24
Could be very worthwhile Investment >20% year
Cutera Inc.
Start price
Target price
Perf. (%)
€2.47
02.05.24
02.05.24
€4.50
02.05.25
02.05.25
-16.88%
13.05.24
13.05.24
Could be very worthwhile Investment >20% year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
-0.75%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Super Micro Computer
Start price
Target price
Perf. (%)
€812.90
29.04.24
29.04.24
€1,000.00
29.04.25
29.04.25
-8.22%
11.05.24
11.05.24
Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€17.72
29.04.24
29.04.24
€25.00
29.04.25
29.04.25
-9.36%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
Bastide Le Confort
Start price
Target price
Perf. (%)
€17.88
27.04.24
27.04.24
-
27.04.25
27.04.25
11.30%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
JFE Holdings Inc
Start price
Target price
Perf. (%)
€13.90
27.04.24
27.04.24
-
27.04.25
27.04.25
0.00%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.28
27.04.24
27.04.24
€2.00
27.04.25
27.04.25
3.55%
13.05.24
13.05.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.68
24.04.24
24.04.24
-
24.04.25
24.04.25
4.63%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.49
23.04.24
23.04.24
€3.00
23.04.25
23.04.25
-8.41%
27.04.24
27.04.24
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.50
19.04.24
19.04.24
-
19.04.25
19.04.25
-12.02%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€3.06
19.04.24
19.04.24
-
19.04.25
19.04.25
-20.98%
10.05.24
10.05.24
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year